Optimi Health Corp. announced that departing of Mr. Michael Stier as director following the Company's Annual General Meeting held January 9, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.405 CAD | -5.81% | +8.00% | +65.31% |
22/05 | Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial | MT |
14/05 | Optimi Health Receives Certificate of Analysis for Mdma 40Mg and 60Mg Gmp Capsules | CI |
1st Jan change | Capi. | |
---|---|---|
+65.31% | 28.55M | |
-.--% | 843M | |
+3.15% | 704M | |
+30.00% | 479M | |
+26.85% | 252M | |
0.00% | 135M | |
+113.04% | 59.39M |
- Stock Market
- Equities
- OPTI Stock
- News Optimi Health Corp.
- Optimi Health Corp. Announces Departs Michael Stier as Director